Literature DB >> 24271210

Cellular and molecular pathways in the tumor immunoenvironment: 3rd Cancer Immunotherapy and Immunomonitoring (CITIM) meeting, 22-25 April 2013, Krakow, Poland.

Michael R Shurin1, Viktor Umansky, Anatoli Malyguine, Arthur A Hurwitz, Ron N Apte, Theresa Whiteside, Anahid Jewett, Yasmin Thanavala, William J Murphy.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 24271210      PMCID： PMC7665797          DOI： 10.1007/s00262-013-1501-z

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN： 0340-7004            Impact factor:   6.968


× No keyword cloud information.
  3 in total

1.  The novel panel assay to define tumor-associated antigen-binding antibodies in patients with metastatic melanomas may have diagnostic value.

Authors:  Beatrix Kotlan; Gabriella Liszkay; Miri Blank; Orsolya Csuka; Timea Balatoni; Laszlo Toth; Klara Eles; Szabolcs Horvath; Gyorgy Naszados; Judit Olasz; Balazs Banky; Jozsef Toth; Maria Godeny; Francesco M Marincola; Miklos Kasler; Yehuda Shoenfeld
Journal:  Immunol Res       Date:  2015-02       Impact factor: 2.829

Review 2.  Adoptive transfer of osteoclast-expanded natural killer cells for immunotherapy targeting cancer stem-like cells in humanized mice.

Authors:  Anna K Kozlowska; Kawaljit Kaur; Paytsar Topchyan; Anahid Jewett
Journal:  Cancer Immunol Immunother       Date:  2016-03-31       Impact factor: 6.968

Review 3.  Natural Killer Cells: Diverse Functions in Tumor Immunity and Defects in Pre-neoplastic and Neoplastic Stages of Tumorigenesis.

Authors:  Anahid Jewett; Janko Kos; Kawaljit Kaur; Tahmineh Safaei; Christine Sutanto; Wuyang Chen; Paul Wong; Artin Keshishian Namagerdi; Changge Fang; Yuman Fong; Meng-Wei Ko
Journal:  Mol Ther Oncolytics       Date:  2019-11-29       Impact factor: 7.200
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.